ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,499,000 | -31.4% | 58,783 | -28.8% | 0.79% | +15.2% |
| Q1 2016 | $2,184,000 | -42.8% | 82,583 | -7.4% | 0.69% | -20.7% |
| Q4 2015 | $3,815,000 | +61.4% | 89,183 | 0.0% | 0.86% | +64.8% |
| Q3 2015 | $2,364,000 | -20.5% | 89,183 | 0.0% | 0.52% | -6.7% |
| Q2 2015 | $2,972,000 | -52.1% | 89,183 | -52.2% | 0.56% | -24.2% |
| Q1 2015 | $6,207,000 | -1.4% | 186,495 | +21.1% | 0.74% | -7.2% |
| Q4 2014 | $6,295,000 | – | 154,025 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |